217 related articles for article (PubMed ID: 33634221)
1. Use of biologics in allergen immunotherapy.
Pfützner W; Schuppe M
Allergol Select; 2021; 5():108-118. PubMed ID: 33634221
[TBL] [Abstract][Full Text] [Related]
2. Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.
Vizzardelli C; Gindl M; Roos S; Möbs C; Nagl B; Zimmann F; Sexl V; Kenner L; Neunkirchner A; Zlabinger GJ; Pickl WF; Pfützner W; Bohle B
Allergy; 2018 Apr; 73(4):851-861. PubMed ID: 29159964
[TBL] [Abstract][Full Text] [Related]
3. Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.
Virkud YV; Wang J; Shreffler WG
Clin Rev Allergy Immunol; 2018 Oct; 55(2):172-189. PubMed ID: 29968170
[TBL] [Abstract][Full Text] [Related]
4. Decline of Ves v 5-specific blocking capacity in wasp venom-allergic patients after stopping allergen immunotherapy.
Möbs C; Müller J; Rudzio A; Pickert J; Blank S; Jakob T; Spillner E; Pfützner W
Allergy; 2015 Jun; 70(6):715-9. PubMed ID: 25753563
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms in AIT: Insights 2021.
Satitsuksanoa P; Angelina A; Palomares O; Akdis M
Allergol Select; 2022; 6():259-266. PubMed ID: 36457721
[TBL] [Abstract][Full Text] [Related]
6. The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis.
Stock P; Rolinck-Werninghaus C; Wahn U; Hamelmann E
BioDrugs; 2007; 21(6):403-10. PubMed ID: 18020623
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation.
Sahiner UM; Giovannini M; Escribese MM; Paoletti G; Heffler E; Alvaro Lozano M; Barber D; Canonica GW; Pfaar O
J Pers Med; 2023 May; 13(5):. PubMed ID: 37241015
[TBL] [Abstract][Full Text] [Related]
8. Overcoming severe adverse reactions to venom immunotherapy using anti-IgE antibodies in combination with a high maintenance dose.
Stretz E; Oppel EM; Räwer HC; Chatelain R; Mastnik S; Przybilla B; Ruëff F
Clin Exp Allergy; 2017 Dec; 47(12):1631-1639. PubMed ID: 28802075
[TBL] [Abstract][Full Text] [Related]
9. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
[TBL] [Abstract][Full Text] [Related]
10. Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses.
Eckl-Dorna J; Villazala-Merino S; Linhart B; Karaulov AV; Zhernov Y; Khaitov M; Niederberger-Leppin V; Valenta R
Front Immunol; 2018; 9():3131. PubMed ID: 30705676
[TBL] [Abstract][Full Text] [Related]
11. Biologics as novel therapeutics for the treatment of allergy: Challenges and opportunities.
Atanasio A; Orengo JM; Sleeman MA; Stahl N
Front Allergy; 2022; 3():1019255. PubMed ID: 36353195
[TBL] [Abstract][Full Text] [Related]
12. Epitope peptides and immunotherapy.
Tanabe S
Curr Protein Pept Sci; 2007 Feb; 8(1):109-18. PubMed ID: 17305564
[TBL] [Abstract][Full Text] [Related]
13. [CROATIAN GUIDELINES FOR IN VITRO DIAGNOSIS OF IgE MEDIATED HYPERSENSITIVITY].
Marković AS; Ivković-Jureković I; Dodig S; Batišta I; Zrinski-Topić R; Barberić M; Topalušić I; Megla ŽB; Žižić V
Acta Med Croatica; 2015; 69(2):75-96. PubMed ID: 29076703
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in allergen immunotherapy.
Nouri-Aria KT
Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
[TBL] [Abstract][Full Text] [Related]
15. Anaphylaxis Associated With Allergen Specific Immunotherapy, Omalizumab, and Dupilumab: A Real World Study Based on the US Food and Drug Administration Adverse Event Reporting System.
Bian S; Zhang P; Li L; Wang Z; Cui L; Xu Y; Guan K; Zhao B; Chen Z
Front Pharmacol; 2021; 12():767999. PubMed ID: 34744748
[No Abstract] [Full Text] [Related]
16. Monitoring Allergen Immunotherapy Effects by Microarray.
Lupinek C; Wollmann E; Valenta R
Curr Treat Options Allergy; 2016; 3():189-203. PubMed ID: 27330931
[TBL] [Abstract][Full Text] [Related]
17. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of Food Allergy: a Comprehensive Review.
Wai CYY; Leung NYH; Leung PSC; Chu KH
Clin Rev Allergy Immunol; 2019 Aug; 57(1):55-73. PubMed ID: 28929421
[TBL] [Abstract][Full Text] [Related]
19. Etiopathogenesis and management of perennial allergic rhinitis: a state-of-the-art review.
Bush RK
Treat Respir Med; 2004; 3(1):45-57. PubMed ID: 15174893
[TBL] [Abstract][Full Text] [Related]
20. Allergen-specific immunosuppression by mucosal treatment with recombinant Ves v 5, a major allergen of Vespula vulgaris venom, in a murine model of wasp venom allergy.
Winkler B; Bolwig C; Seppälä U; Spangfort MD; Ebner C; Wiedermann U
Immunology; 2003 Nov; 110(3):376-85. PubMed ID: 14632666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
